Year | Staging | Total (%) | |||
---|---|---|---|---|---|
Localized stage (%) | Locally advanced stage (%) | Metastatic stage (%) | No classified (%) | ||
2017 | 5(1.0) | 3(0.6) | 27(5.3) | 5(1.0) | 40(7.9) |
2016 | 6(1.0) | 2(0.3) | 12(2.0) | 13(2.2) | 33(5.5) |
2015 | 8(1.5) | 3(0.5) | 19(3.4) | 9(1.6) | 39(7.0) |
2014 | 14(2.2) | 3(0.5) | 17(2.7) | 9(1.4) | 43(6.9) |
2013 | 13(2.0) | 2(0.3) | 19(3.0) | 10(1.6) | 44(6.9) |
Total | 46(1.6) | 13(0.4) | 94(3.2) | 46(1.6) | 199(6.8) |